Nov Santé

Overview

Nov Santé is a French private equity firm specializing in healthcare investments. The firm focuses on supporting European small and medium-sized enterprises (SMEs) in the healthcare sector, aiming to strengthen healthcare systems and promote innovation within the industry. Nov Santé is managed by Eurazeo, a leading European investment group, and was launched at the initiative of France Assureurs and Caisse des Dépôts. The firm's investment strategy involves providing growth equity and buyout capital to companies operating in various healthcare sub-sectors, including education, pharmaceuticals, biotechnology, and medical devices. Nov Santé seeks to partner with management teams to accelerate growth, enhance operational efficiency, and expand market reach. The firm typically invests between €10 million and €40 million per company, focusing on businesses with strong development potential and a commitment to improving healthcare services. Since its inception, Nov Santé has made several notable investments, including a €29 million Series B funding round in Germitec, a French MedTech company specializing in high-level disinfection solutions for ultrasound probes. Additionally, Nov Santé invested in Kinvent, a provider of connected solutions for physical therapy, and supported the acquisition of ZoBio by Oncodesign Services, enhancing its pre-clinical research capabilities. These investments reflect Nov Santé's commitment to advancing healthcare innovation and supporting the growth of SMEs in the sector.

Investment Focus

• Strong management team
• Innovative products or services
• Scalable business model
• Commitment to improving healthcare services
• Potential for market expansion

Portfolio Companies